Regulus Therapeutics (NASDAQ:RGLS)

CAPS Rating: 1 out of 5

Results 1 - 2 of 2

Recs

0
Member Avatar usubanas (99.73) Submitted: 10/23/2014 1:22:41 PM : Underperform Start Price: $14.01 RGLS Score: -31.24

HCV results not that great to justify a 600M mc.

Recs

0
Member Avatar rknapton (< 20) Submitted: 8/22/2013 4:56:09 PM : Underperform Start Price: $9.51 RGLS Score: -77.16

Short. Biotech. High P/S ratio.

Results 1 - 2 of 2

Featured Broker Partners


Advertisement